Transmedics Group Q3 EPS USD 0.46

TMDX•2026-11-05

Transmedics Group reported Q3 revenue of USD 203 million, gross margin of 58.5% and net income of USD 17.1 million; it forecast FY revenue of USD 764 million to USD 774 million.

1. Q3 results and outlook

Transmedics Group reported Q3 revenue of USD 203 million, compared with the IBES estimate of USD 177.6 million, and earnings per share of USD 0.46. It forecast FY revenue of USD 764 million to USD 774 million, versus the IBES estimate of USD 743.8 million.

Transmedics Group Q3 EPS USD 0.46

1. Q3 results and outlook

Related News

MannKind swings to Q3 2026 net loss of $23.22 million from year-earlier profit

Saul Centers Q3 rental revenue $76.953 million

Live Nation Q3 revenue $10,100 million vs. IBES estimate $9,593 million

CareTrust REIT Q3 net income $83.7 million vs. IBES estimate of $99.1 million

Neptune Insurance CEO Trevor R. Burgess reports sale of $3.46 million in common shares